EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Cancer Mitochondria with Stimuli-Responsive Nanocarriers: Emerging Strategies for Precision Oncology

Kartik Bhatnagar, Geeta Swargiary, Sakshi Tyagi, Aditi Kaushik, Vaibhav Mani Tripathi, Keshav K. Singh, Shalini Mani

Cells · 11.11.2026 · 15 (22) · 2045

DOI: 10.3390/cells15222045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 11.11.2026. Verfasst von Kartik Bhatnagar und 6 weiteren Autor:innen. Die Arbeit nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria are central regulators of cancer cell survival, metabolism, and therapy resistance, making them a promising yet underutilized target in modern oncology. Internal stimuli such as altered redox balance, elevated reactive oxygen species (ROS), and acidic pH uniquely characterize the tumor microenvironment, providing a distinct trigger for smart drug delivery. Internal stimuli-responsive nanocarriers have emerged as an innovative strategy to achieve spatiotemporal control of drug release while selectively homing to subcellular organelles such as mitochondria. This review outlines the multifaceted role of mitochondria in cancer progression, chemoresistance, and metastasis, and highlights the unique biochemical hallmarks of cancer cells that facilitate targeted delivery. We further explore recent advances in the development of pH-, redox-, ROS-, and enzyme-sensitive nanocarriers that exploit these internal cues to localize chemotherapeutic agents specifically to cancerous mitochondria. We also compare their advantages and limitations with conventional chemotherapy and other targeting approaches. Additionally, translational challenges, limitations, and future directions including vesicle-mediated mitochondria transfer are discussed, aiming to reduce systemic toxicity while improving therapeutic efficacy.

Zitieren

APA

Bhatnagar, K., Swargiary, G., Tyagi, S., Kaushik, A., Tripathi, V. M., Singh, K. K., & Mani, S. (2026). Targeting Cancer Mitochondria with Stimuli-Responsive Nanocarriers: Emerging Strategies for Precision Oncology. Cells, 15(22), 2045. https://doi.org/10.3390/cells15222045

Vancouver

Bhatnagar K, Swargiary G, Tyagi S, Kaushik A, Tripathi VM, Singh KK, et al. Targeting Cancer Mitochondria with Stimuli-Responsive Nanocarriers: Emerging Strategies for Precision Oncology. Cells. 2026;15(22):2045. doi:10.3390/cells15222045

BibTeX
@article{Bhatnagar2026,
  author = {Bhatnagar, Kartik and Swargiary, Geeta and Tyagi, Sakshi and Kaushik, Aditi and Tripathi, Vaibhav Mani and Singh, Keshav K. and Mani, Shalini},
  title = {Targeting Cancer Mitochondria with Stimuli-Responsive Nanocarriers: Emerging Strategies for Precision Oncology},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {22},
  pages = {2045},
  doi = {10.3390/cells15222045}
}
Kostenlos starten →